NO20051468L - Behandling av ikke-allergisk rhinitt med selektive fosfodiesterase-4-inhibitorer - Google Patents

Behandling av ikke-allergisk rhinitt med selektive fosfodiesterase-4-inhibitorer

Info

Publication number
NO20051468L
NO20051468L NO20051468A NO20051468A NO20051468L NO 20051468 L NO20051468 L NO 20051468L NO 20051468 A NO20051468 A NO 20051468A NO 20051468 A NO20051468 A NO 20051468A NO 20051468 L NO20051468 L NO 20051468L
Authority
NO
Norway
Prior art keywords
inhibitors
treatment
allergic rhinitis
selective phosphodiesterase
phosphodiesterase
Prior art date
Application number
NO20051468A
Other languages
English (en)
Inventor
Norbert Hofgen
Hildegard Kuss
Chris Rundfeldt
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of NO20051468L publication Critical patent/NO20051468L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen angår anvendelsen av hydroksylindolyl-glyoksyl-syreamider som hemmere av fosfodiesterase-4 for behandling av ikke-allergisk rhinitt.
NO20051468A 2002-09-06 2005-03-21 Behandling av ikke-allergisk rhinitt med selektive fosfodiesterase-4-inhibitorer NO20051468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10241407A DE10241407A1 (de) 2002-09-06 2002-09-06 Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe
PCT/EP2003/009895 WO2004022041A2 (de) 2002-09-06 2003-09-05 Behandlung nicht allergischer rhinitis durch selektive phosphodiesterase 4-hemmstoffe

Publications (1)

Publication Number Publication Date
NO20051468L true NO20051468L (no) 2005-06-03

Family

ID=31724458

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051468A NO20051468L (no) 2002-09-06 2005-03-21 Behandling av ikke-allergisk rhinitt med selektive fosfodiesterase-4-inhibitorer

Country Status (18)

Country Link
US (1) US20040116501A1 (no)
EP (1) EP1534272A2 (no)
JP (1) JP2005539058A (no)
KR (1) KR20050034760A (no)
CN (1) CN1678307A (no)
AR (1) AR041172A1 (no)
AU (1) AU2003271586A1 (no)
BR (1) BR0314031A (no)
CA (1) CA2497374A1 (no)
DE (1) DE10241407A1 (no)
HR (1) HRP20050310A2 (no)
MX (1) MXPA05002437A (no)
NO (1) NO20051468L (no)
PL (1) PL375494A1 (no)
RU (1) RU2005109939A (no)
TW (1) TW200404777A (no)
WO (1) WO2004022041A2 (no)
ZA (1) ZA200501582B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004270733B2 (en) 2003-09-11 2011-05-19 Itherx Pharma, Inc. Cytokine inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions
DE19818964A1 (de) * 1998-04-28 1999-11-04 Dresden Arzneimittel Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань

Also Published As

Publication number Publication date
PL375494A1 (en) 2005-11-28
DE10241407A1 (de) 2004-03-18
AU2003271586A1 (en) 2004-03-29
EP1534272A2 (de) 2005-06-01
JP2005539058A (ja) 2005-12-22
TW200404777A (en) 2004-04-01
BR0314031A (pt) 2005-07-05
CA2497374A1 (en) 2004-03-18
MXPA05002437A (es) 2005-06-03
KR20050034760A (ko) 2005-04-14
HRP20050310A2 (en) 2005-06-30
US20040116501A1 (en) 2004-06-17
WO2004022041A2 (de) 2004-03-18
ZA200501582B (en) 2005-09-09
RU2005109939A (ru) 2005-09-10
WO2004022041A3 (de) 2004-05-06
CN1678307A (zh) 2005-10-05
AR041172A1 (es) 2005-05-04

Similar Documents

Publication Publication Date Title
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
EA200601391A1 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
NO20050199L (no) Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
IS7710A (is) Heterósýklísk setin píperasín til notkunar við meðferð á geðklofa
NO20074959L (no) Substituerte pyridinderivater
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
BRPI0414792A (pt) derivados de ácido 4-(1h-indol-3-il-metilidenoaminóxi-propóxi)-benzóico e compostos relacionados como inibidores de pai-1 para o tratamento de enfraquecimento do sistema fibrinolìtico e de trombose
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
NO20061137L (no) Cyklopropylderivater som NK3-reseptorantagonister
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20062417L (no) N-tiazol-2-yl-benzamidderivater
ATE471326T1 (de) Substituierte thienopyrrolcarbonsäureamide, pyrrolothiazolcarbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i- epsilon
WO2006023866A3 (en) Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20071805L (no) Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
NO20051468L (no) Behandling av ikke-allergisk rhinitt med selektive fosfodiesterase-4-inhibitorer